Galaxy银河|澳门官网·登录入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

CPF impedes cell cycle re-entry of quiescent lung cancer cells through transcriptional suppression of FACT and c-MYC

J Cell Mol Med. 2020; 
Bi L, Xie C, , Jiao L, Jin S, Hnit SST, , Mu Y, Wang Y, Wang Q, Ge G, Wang Y, Zhao X, Shi X, Kang Y, De Souza P, Liu T, Zhou J, Xu L, Dong Q, .
Products/Services Used Details Operation
Gene Synthesis … The SPT16 (OHu22815D) and SSRP1 (OHu17195D) plasmid were obtained from GenScript Company and transfected into cells with Lipofectamine™ RNAiMAX (Invitrogen, Life Technologies) 24 SYBR green assay Quiescent … Get A Quote

摘要

Blockade of cell cycle re-entry in quiescent cancer cells is a strategy to prevent cancer progression and recurrence. We investigated the action and mode of action of CPF mixture (Coptis chinensis, Pinellia ternata and Fructus trichosanthis) in impeding a proliferative switch in quiescent lung cancer cells. The results indicated that CPF impeded cell cycle re-entry in quiescent lung cancer cells by reduction of FACT and c-MYC mRNA and protein levels, with concomitant decrease in H3K4 tri-methylation and RNA polymerase II occupancy at FACT and c-MYC promoter regions. Animals implanted with quiescent cancer cells that had been exposed to CPF had reduced tumour volume/weight. Thus, CPF suppresses proliferative swi... More

关键词

XML 地图